Juno Therapeutics Reports Exclusive Collaboration Deal with Editas Medicine for Creation of Next-Gen CAR T, TCR Cell Therapies
May 27, 2015 at 07:35 AM EDT
Juno Therapeutics, Inc., a leading biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the ...
